Fortescue Ltd
FMG
Woodside Energy Group Ltd
WDS
BHP Group Ltd
BHP
Rio Tinto Ltd
RIO
Telstra Group Ltd
TLS
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products.